Dr Reddy’s Laboratories’ eagerness to acquire Betapharm is evident in the high price it has paid, but longer term considerations seem to have weighed on its mind as it signed on the dotted line.
Click the following link http://ww4.6URL.com/0FY2 to read the complete article.
